M2 Pharma - Therapy Areas

Newly Published Research Demonstrates Ability of Hologic's Assay to Detect Mycoplasma Genitalium, "the Silent Epidemic"

14 November 2019 - - A newly published study demonstrates clinical evidence for the effectiveness of a first-of-its-kind, FDA-cleared assay for the detection of the sexually transmitted bacterium ...

Johnson & Johnson to invest more than USD500m in next four years

8 October 2019 - United States-based Johnson & Johnson is planning to invest more than USD500m in the next four years to help end the epidemics of HIV and tuberculosis, it was reported yesterday.T...

US Food and Drug Administration Approves Descovy for HIV Pre-Exposure Prophylaxis

7 October 2019 - - The US Food and Drug Administration approved a pre-exposure prophylaxis indication for Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF), US-based Gilead...

Gilead Sciences' Descovy granted US FDA approval

7 October 2019 - The US Food and Drug Administration (FDA) has granted approval to United States-based Gilead Sciences for HIV pre-exposure prophylaxis indication of Descovy (emtricitabine 200mg and t...

FDA approves Descovy for pre-exposure prophylaxis to prevent HIV infection

4 October 2019 - The US Food and Drug Administration (FDA) said on Thursday that it has granted approval to Gilead Sciences Inc (NASDAQ:GILD) for Descovy (emtricitabine 200 mg and tenofovir alafenamid...

Celltrion to launch Temixys in US

2 October 2019 - South Korea-based Celltrion is introducing its HIV drug Temixys in the United States, it was reported yesterday.The United States Food and Drug Administration (FDA) approved the produ...